Compare NEXN & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEXN | THW |
|---|---|---|
| Founded | 2007 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Finance Companies |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.5M | 484.8M |
| IPO Year | 2021 | 2015 |
| Metric | NEXN | THW |
|---|---|---|
| Price | $8.79 | $12.99 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $14.34 | N/A |
| AVG Volume (30 Days) | ★ 351.4K | 104.1K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.30 | N/A |
| Revenue Next Year | $8.79 | N/A |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.60 | $11.18 |
| 52 Week High | $11.30 | $14.50 |
| Indicator | NEXN | THW |
|---|---|---|
| Relative Strength Index (RSI) | 47.30 | 55.46 |
| Support Level | $8.57 | $12.76 |
| Resistance Level | $9.21 | $13.76 |
| Average True Range (ATR) | 0.40 | 0.28 |
| MACD | 0.03 | 0.10 |
| Stochastic Oscillator | 58.18 | 72.65 |
Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and TV that helps empower advertisers, agencies, digital publishers, broadcasters, and others. The Digital Advertising Ecosystem of the company includes demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. The company operates in America, APAC, EMEA, and Rest of America, with majority revenue from United States.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.